August 30, 2012
Immuno-Biological Laboratories (IBL) announced on August 29 that the company and the Institute of Biological Resources (IBR; Nago, Okinawa Prefecture) will codevelop viral vaccines by using transgenic silkworms with the aim of commercialization. IBL will use transgenic silkworm technology to...read more